DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

Medical device makers must balance PFAS performance benefits with health risks, preparing for regulation by auditing ...

The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion ...

Atraverse Medical, a San Diego-based medical device company pioneering universally-compatible transseptal access technology, announced today that the latest clinical evidence on the efficacy and ...

Rivermark Medical, a urology-focused medical device company committed to redefining benign prostatic hyperplasia (BPH) treatment through simple, innovative solutions, today announced the enrollment of ...

Rivermark Medical, a urology-focused medical device company committed to redefining benign prostatic hyperplasia (BPH) ...

CereVasc announced today that it received FDA breakthrough device designation for its investigational eShunt system.

Symposium will also feature presentation on the BACKBEAT global pivotal study Orchestra BioMed is currently enrolling in strategic collaboration with Medtronic, plc (NYSE: MDT) ...

CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today ...

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

Short Summary The EU, UK, and USA each have distinct and evolving regulatory systems for medicines and medical devices, involving strict approval, surveillance, and market access requirements managed ...